Market Tracker

09/02 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

During the Trading Day
5.49 -0.35 / -5.99%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.60 +0.11 / +2.00%
 
Volume: 100.00

Today’s Trading

Previous close5.84
Today’s open6.03
Day’s range5.00 - 6.04
Volume601,730
Average volume (3 months)132,953
Market cap$110.4M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-5.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.41+4.63%
CGIXCancer Genetics Inc+0.12+1.35%
GALTGalectin Therapeutic...-0.10-1.60%
ERBERBA Diagnostics Inc-0.04-1.10%
Data as of 4:00pm ET, 09/02/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts